Table 1.

Observed and predicted global vaccine coverage, stratified by antigen and year.

	2020				2021
Antigen/Dose	Countries	Observed Coverage (%)	Predicted Coverage (%)	Observed - Predicted (% [95 % PI])	Countries	Observed Coverage (%)	Predicted Coverage (%)	Observed - Predicted (% [95 % PI])
BCG	124	87.3	88.4	−1.11 [−1.56 to −0.66]	113	86.7	88.2	−1.52 [−2.24 to −0.81]
DTPCV1	135	91.7	92.9	−1.19 [−1.38 to −1.00]	122	90.3	92.5	−2.16 [−2.45 to −1.87]
DTPCV3	149	87.7	89.5	−1.82 [−2.14 to −1.51]	137	86.4	89.3	−2.85 [−3.39 to −2.32]
HEPB_BD	44	84.6	86.3	−1.68 [−2.42 to −0.94]	39	83.1	84.9	−1.77 [−3.28 to −0.26]
HEPB3	122	86.7	89.1	−2.42 [−2.73 to −2.11]	111	86.6	90.0	−3.42 [−3.71 to −3.12]
HIB3	117	87.1	89.0	−1.89 [−2.19 to −1.60]	109	85.6	88.7	−3.04 [−3.45 to −2.63]
HPV_FEM	6	62.8	67.6	−4.81 [−10.13 to 0.51]	6	56.5	69.2	−12.76 [−19.56 to −5.95]
IPV1	74	91.5	99.4	−7.91 [−8.51 to 0.54]	63	89.4	100.0	−10.64 [−10.64 to −3.96]
MCV1	146	87.2	88.8	−1.58 [−2.08 to −1.08]	134	85.2	88.7	−3.53 [−4.26 to −2.81]
MCV2	102	83.5	86.0	−2.51 [−3.48 to −1.55]	92	79.8	86.3	−6.52 [−7.85 to −5.20]
PCV1	79	91.0	93.7	−2.74 [−4.28 to −1.21]	73	90.1	93.9	−3.83 [−5.51 to −2.15]
PCV2	78	86.7	91.0	−4.24 [−5.65 to −2.84]	70	85.0	91.5	−6.43 [−7.96 to −4.90]
POL3	140	86.7	88.5	−1.85 [−2.73 to −0.97]	125	84.5	88.1	−3.64 [−5.14 to −2.14]
RCV1	92	90.5	93.3	−2.76 [−3.59 to −1.92]	83	89.1	93.1	−4.00 [−5.07 to −2.93]
ROTA1	55	86.8	89.0	−2.19 [−4.84 to 0.47]	50	84.0	89.0	−5.03 [−8.62 to −1.43]
ROTAC	54	83.3	87.6	−4.29 [−6.45 to −2.13]	49	79.6	87.9	−8.30 [−11.01 to −5.60]

PI = prediction interval.